Antibody-based capture of 2019-nCoV and its inactivation using lipid-based in situ gel
Implementing Organization
Indian Institute of Technology (IIT)
Principal Investigator
Dr. Kiran Kondabagil
Associate Professor, Indian Institute of Technology (IIT), Mumbai
Project Overview
The project aims to develop antibodies against the receptor-binding domain of the spike glycoprotein of CoV involved in recognizing a host cell-surface receptor, namely, zinc peptidase angiotensin-converting enzyme 2. Another objective is to develop unsaturated free fatty acid-based emulsion loaded in-situ gels to inactivate the virus at the point of entry.
Indian Institute of Technology (IIT)
Accessibility Controls
